Esperion Therapeutics
ESPR
#7605
Rank
โ‚ฌ0.27 B
Marketcap
1,33ย โ‚ฌ
Share price
-4.00%
Change (1 day)
-48.50%
Change (1 year)

Esperion Therapeutics (ESPR) - Total liabilities

Total liabilities on the balance sheet as of December 2024 : โ‚ฌ0.67 Billion

According to Esperion Therapeutics's latest financial reports the company's total liabilities are โ‚ฌ0.67 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Esperion Therapeutics - Total liabilities on balance sheet (from 2001 to 2024)

Total liabilities by year

Year Total liabilities Change
2024-12-31โ‚ฌ0.70 B17.77%
2023-12-31โ‚ฌ0.59 B12.15%
2022-12-31โ‚ฌ0.53 B4.33%
2021-12-31โ‚ฌ0.51 B39.82%
2020-12-31โ‚ฌ0.36 B110.44%
2019-12-31โ‚ฌ0.17 B208.74%
2018-12-31โ‚ฌ56.23 M103.58%
2017-12-31โ‚ฌ27.62 M74.92%
2016-12-31โ‚ฌ15.79 M107.71%
2015-12-31โ‚ฌ7.6 M-4.89%
2014-12-31โ‚ฌ7.99 M162.65%
2013-12-31โ‚ฌ3.04 M-83.7%
2012-12-31โ‚ฌ18.67 M194.44%
2011-12-31โ‚ฌ6.34 M
2002-12-31โ‚ฌ12.11 M-9.65%
2001-12-31โ‚ฌ13.4 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
โ‚ฌ1.14 B 69.43%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ1.23 B 81.69%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ115.48 B 16,950.06%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ7.77 B 1,047.48%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ0.54 B-19.32%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ0.14 B-79.19%๐Ÿ‡บ๐Ÿ‡ธ USA